300791.SZ
仙乐健康
SZSE · Consumer Defensive · C 制造业 · CN
CNY 16.98
+2.66%Year over year
Reported trailing growth
- Revenue
- +2.3%
- EBITDA
- —
- EBIT
- —
- EPS
- -64.5%
- Free cash flow
- -87.4%
- Operating cash flow
- -30.0%
Forward estimates
Based on analyst estimates
- Revenue
- -74.8%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +19.4%
- EBITDA
- -13.9%
- EBIT
- -68.4%
- Net income
- -13.7%
- EPS
- -27.6%
- Free cash flow
- -5.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026